Intra-Cellular Therapies - Stock Price History | ITCI
Historical daily share price chart and data for Intra-Cellular Therapies since 2023 adjusted for splits. The latest closing stock price for Intra-Cellular Therapies as of January 27, 2023 is 47.75.
- The all-time high Intra-Cellular Therapies stock closing price was 65.64 on April 06, 2022.
- The Intra-Cellular Therapies 52-week high stock price is 66.00, which is 38.2% above the current share price.
- The Intra-Cellular Therapies 52-week low stock price is 42.42, which is 11.2% below the current share price.
- The average Intra-Cellular Therapies stock price for the last 52 weeks is 53.18.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Intra-Cellular Therapies Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2022 |
52.7320 |
52.0200 |
65.6400 |
38.7400 |
52.9200 |
1.11% |
| 2021 |
37.1357 |
31.6900 |
53.4200 |
28.7200 |
52.3400 |
64.59% |
| 2020 |
22.7824 |
33.1200 |
33.1200 |
12.3100 |
31.8000 |
-7.32% |
| 2019 |
11.7823 |
11.5200 |
38.4900 |
7.2600 |
34.3100 |
201.23% |
| 2018 |
19.2115 |
15.1600 |
25.4900 |
10.3600 |
11.3900 |
-21.34% |
| 2017 |
14.0433 |
15.7300 |
22.1000 |
9.2600 |
14.4800 |
-4.04% |
| 2016 |
30.9926 |
53.6300 |
54.3200 |
10.8700 |
15.0900 |
-71.95% |
| 2015 |
32.8543 |
17.5700 |
58.7600 |
16.4500 |
53.7900 |
204.76% |
| 2014 |
16.2958 |
15.0000 |
20.2500 |
13.0800 |
17.6500 |
0.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$4.619B |
$0.084B |
|
Intra-Cellular Therapies Inc. is a biopharmaceutical company. The company develops drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the central nervous system. Its product candidates include ITI-007, ITI-002 and ITI-009 which is in clinical trials. Intra-Cellular Therapies Inc. is headquartered in New York.
|
